Mechanically, we indicated that METTL3-mediated m6A modification on FAM120A mRNA enhanced FAM120A expression in an m6A-YTHDC1-dependent manner, which further promoted cisplatin resistance of GC cells. Here, METTL3 is linked to gastric cancer.